Shares

8 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Feb 01, 2023

SELL
$41.75 - $54.5 $4,008 - $5,232
-96 Reduced 1.77%
5,339 $273,000
Q3 2022

Oct 25, 2022

SELL
$43.76 - $53.42 $23,630 - $28,846
-540 Reduced 9.04%
5,435 $238,000
Q2 2022

Jul 27, 2022

BUY
$46.53 - $55.17 $6,932 - $8,220
149 Added 2.56%
5,975 $313,000
Q4 2021

Jan 24, 2022

SELL
$41.32 - $61.25 $5,412 - $8,023
-131 Reduced 2.2%
5,826 $344,000
Q3 2021

Oct 26, 2021

SELL
$39.25 - $50.42 $73,593 - $94,537
-1,875 Reduced 23.94%
5,957 $253,000
Q2 2021

Jul 26, 2021

BUY
$35.91 - $40.68 $8,438 - $9,559
235 Added 3.09%
7,832 $307,000
Q1 2021

May 04, 2021

SELL
$33.49 - $37.77 $26,792 - $30,216
-800 Reduced 9.53%
7,597 $276,000
Q4 2020

Feb 10, 2021

BUY
$33.47 - $42.56 $281,047 - $357,376
8,397 New
8,397 $304,000

Others Institutions Holding PFE

About PFIZER INC


  • Ticker PFE
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 5,612,349,952
  • Market Cap $150B
  • Description
  • Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...
More about PFE
Track This Portfolio

Track Montis Financial, LLC Portfolio

Follow Montis Financial, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Montis Financial, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Montis Financial, LLC with notifications on news.